NRAS and neoplasm: Increasing tumor size, extrahepatic disease, higher CA 19-9 levels, portal vein thrombus, the presence of satellite lesions, and IDH1, TP53, and NRAS mutations were all significantly associated with an increased likelihood of intrahepatic distant metastasis.